Scott Peak

2.8k total citations
9 papers, 640 citations indexed

About

Scott Peak is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Scott Peak has authored 9 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Scott Peak's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Cancer Treatment and Pharmacology (2 papers). Scott Peak is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Cancer Treatment and Pharmacology (2 papers). Scott Peak collaborates with scholars based in United States. Scott Peak's co-authors include Lauren E. Abrey, Meltem Ekenel, Lisa M. DeAngelis, Adı́lia Hormigo, Timothy F. Cloughesy, Albert Lai, Phioanh L. Nghiemphu, Tatjana Kolevska, Surasak Phuphanich and Jonathan Polikoff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Pain.

In The Last Decade

Scott Peak

9 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Peak United States	7	438	281	209	135	131	9	640
Marina Faedi Italy	13	412 0.9×	213 0.8×	199 1.0×	164 1.2×	157 1.2×	27	710
Ivan Lolli Italy	13	388 0.9×	197 0.7×	190 0.9×	202 1.5×	158 1.2×	40	672
Emese Filka United States	6	533 1.2×	202 0.7×	128 0.6×	197 1.5×	240 1.8×	9	672
Alfred Yung United States	16	370 0.8×	179 0.6×	167 0.8×	150 1.1×	279 2.1×	29	672
Javier Gonzalez United States	7	401 0.9×	272 1.0×	151 0.7×	94 0.7×	144 1.1×	13	692
L. Scopece Italy	10	539 1.2×	360 1.3×	116 0.6×	157 1.2×	240 1.8×	18	750
Robert Nordal Canada	14	330 0.8×	413 1.5×	193 0.9×	88 0.7×	125 1.0×	27	825
Richard Zuniga United States	6	360 0.8×	211 0.8×	89 0.4×	141 1.0×	121 0.9×	16	498
Michael Prados United States	15	522 1.2×	206 0.7×	152 0.7×	105 0.8×	226 1.7×	39	794
L. E. Abrey United States	6	386 0.9×	169 0.6×	108 0.5×	106 0.8×	144 1.1×	6	466

Countries citing papers authored by Scott Peak

Since Specialization

Citations

This map shows the geographic impact of Scott Peak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Peak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Peak more than expected).

Fields of papers citing papers by Scott Peak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Peak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Peak. The network helps show where Scott Peak may publish in the future.

Co-authorship network of co-authors of Scott Peak

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Peak. A scholar is included among the top collaborators of Scott Peak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Peak. Scott Peak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Levin, Victor A., et al.. (2015). Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma. Journal of Neuro-Oncology. 122(1). 145–150. 53 indexed citations

Lai, Albert, Anh Tran, Phioanh L. Nghiemphu, et al.. (2010). Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 29(2). 142–148. 353 indexed citations

Lai, Albert, Scott Peak, Surasak Phuphanich, et al.. (2009). Phase II trial of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme. Journal of Clinical Oncology. 27(15_suppl). 2000–2000. 15 indexed citations

Staud, Roland, Erin M. O’Brien, Jason G. Craggs, et al.. (2008). (368) Fibromyalgia patients have high expectations of symptom relief during rheumatology office visits. Journal of Pain. 9(4). 68–68. 1 indexed citations

Iwamoto, Fábio M., Jazmin Schwartz, Neeta Pandit‐Taskar, et al.. (2007). Study of radiolabeled indium‐111 and yttrium‐90 ibritumomab tiuxetan in primary central nervous system lymphoma. Cancer. 110(11). 2528–2534. 41 indexed citations

Ekenel, Meltem, Adı́lia Hormigo, Scott Peak, Lisa M. DeAngelis, & Lauren E. Abrey. (2007). Capecitabine Therapy of Central Nervous System Metastases from Breast Cancer. Journal of Neuro-Oncology. 85(2). 223–227. 120 indexed citations

Peak, Scott & Lauren E. Abrey. (2006). Chemotherapy and the Treatment of Brain Metastases. Hematology/Oncology Clinics of North America. 20(6). 1287–1295. 9 indexed citations

Kaleita, Thomas A., David K. Wellisch, Colin A. Graham, et al.. (2006). Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. Journal of Clinical Oncology. 24(18_suppl). 1503–1503. 45 indexed citations

Peak, Scott, Denice Tsao‐Wei, & Marc C. Chamberlain. (2006). Mitoxantrone in secondary progressive multiple sclerosis: a review of toxicity in 41 patients. Therapy. 4(1). 55–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact